GPC Biotech (also referred to as ''GPCbiotech'' and ''GPC-Biotech'') was a German
biopharmaceutical
A biopharmaceutical, also known as a biological medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, t ...
company. The company's mission statement reads "... to discover, develop and commercialize new anticancer drugs."
Founded in 1997, the company was held privately until May 2000 when an
initial public offering
An initial public offering (IPO) or stock launch is a public offering in which shares of a company are sold to institutional investors and usually also to retail (individual) investors. An IPO is typically underwritten by one or more investme ...
was made on the now defunct German Neuer Markt. Subsequent to the closing of the Neuer, GPC refinanced in June 2004 through a public stock offering and listed
ADRs on
NASDAQ.
In March 2000, the company acquired Mitotix, a United States biotechnology firm located in
Cambridge, Massachusetts
Cambridge ( ) is a city in Middlesex County, Massachusetts, United States. As part of the Boston metropolitan area, the cities population of the 2020 U.S. census was 118,403, making it the fourth most populous city in the state, behind Boston ...
. This acquisition has led to the company having ~50% of its employees based in the United States and the remaining 50% in Germany. Further, the acquisition of Mitotix provided convenient proximity to GPC's long term and continuing collaboration with ALTANA Pharma AG and the ALTANA Research Institute, located in
Waltham, Massachusetts
Waltham ( ) is a city in Middlesex County, Massachusetts, United States, and was an early center for the labor movement as well as a major contributor to the American Industrial Revolution. The original home of the Boston Manufacturing Company, ...
.
In November 2009, Agennix AG acquired GPC Biotec
In 2013 Agennix AG went into liquidation.
Products
As of July 2005, the company does not have a marketed product, though it has three therapeutics in its
drug discovery pipeline as shown in the table below.
Notes
# Mission statement obtained from http://www.gpc-biotech.com/en/about_the_company/index.html. Retrieved July 9, 2005.
# A portion of basic corporate information was obtained fro
the Hoover's Online Fact Sheet for GPC Biotech AG Retrieved July 9, 2005.
# reference
Annual Report for the year 2000 Retrieved July 11, 2005.
# reference
Annual Report for the year 2004 Retrieved July 11, 2005.
{{Authority control
Companies listed on the Frankfurt Stock Exchange
Biotechnology companies of Germany
Biotechnology companies established in 1997
Biotechnology companies disestablished in 2013
Defunct companies of Germany
German companies established in 1997
German companies disestablished in 2013